Precautions & Notes GHK-Cu activity is concentration-dependent
a ) Change in cell growth in HCT116 cells treated with 5FU as indicated over 72 h measured by SRB assay
Scientific Reference 4 (Circadian / Microbiome Rhythm & Stability): Thaiss et al., Science (2016) This research highlights that disrupting circadianmicrobial oscillations impairs metabolic homeostasis, glucose regulation, microbial balance, and stability illustrating why long-term metabolic health requires rebuilding the microbiome and circadian/metabolic rhythms, not just using drugs
Some GLP-1s, like Ozempic, Mounjaro (tirzepatide), and Victoza (liraglutide), are approved to treat type 2 diabetes, meaning these medications are only prescribed if you have type 2 diabetes
These are similar to other GLP-1 medications, but the intensity and severity of these side effects are slightly higher with retatrutide
1 When diabetic patients are not at risk of DKA, basal insulin plus noninsulin hypoglycemic agents with weight loss effects are recommended for those with preobesity/obesity or without weight loss, and basal insulin/premix insulin plus secretagogues or DPP-4i are recommended for those without preobesity/obesity and with weight loss concerns